Advertisement

Organisation › Details
Abcam plc (AIM: ABC, Nasdaq: ABCM)
Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and to improve the understanding of health and disease. Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company’s catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work. Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support to over 100 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM: ABC). *
![]() |
Start | 1998-01-01 splitoff predec |
Group | Danaher (Group) | |
Predecessor | Abcam Ltd. | |
![]() |
Industry | research antibody |
![]() |
Person | Hirzel, Alan (Abcam 201409– CEO before Chief Marketing Officer) |
Person 2 | Milner, Jonathan (Abcam 201409 Deputy Chairman + largest shareholder before CEO + Co-founder) | |
![]() |
Region | Cambridge, Cambridgeshire |
Country | United Kingdom (GB) | |
Street | Cambridge Science Park | |
City | CB4 0FW Cambridge | |
Tel | +44-1223-696000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2020-10-19) |
Currency | GBP | |
Annual sales | 260,000,000 (revenue (2019/20) 2020-06-30) | |
Profit | 12,500,000 (2020-06-30) | |
Cash | 291,600,000 (2020-06-30) | |
* Document for »About Section«: | ||
Record changed: 2024-08-22 |
Advertisement

More documents for Danaher (Group)
- [1] Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne....
- [2] SphingoTec GmbH. (10/9/24). "Press Release: Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care". Hennigsdorf....
- [3] CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome....
- [4] Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel....
- [5] Eppendorf SE. (8/30/24). "Press Release: Dr. Christine Munz Becomes CEO at Eppendorf". Hamburg....
- [6] Genedata AG. (8/19/24). "Press Release: Genedata Joins Danaher Corporation". Basel....
- [7] Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg....
- [8] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [9] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
- [10] Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top